Moderna signs MoU to build mRNA manufacturing facility in Kenya
The company intends to make an investment of up to $500m in the manufacturing facility in Kenya.

The company intends to make an investment of up to $500m in the manufacturing facility in Kenya.
CSPC NBP Pharmaceutical, a subsidiary of CSPC Pharmaceutical Group, has signed an equity transfer and capital increase agreement with Wuhan…
Thank you for subscribing to Pharmaceutical Technology